NeuGene (AVI BioPharma)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameNeuGene (AVI BioPharma)

Drug Alias NameHMG CoA reductase inhibitor (AVI BioPharma)cholesterol-lowering antisense therapy (AVI BioPharma)hypercholesterolemia antisense therapy (AVI BioPharma)NeuGene (AVI BioPharma)HMG CoA reductase inhibitor (AVI BioPharma)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionHMG-CoA reductase inhibitors

TargetsHMG-CoA reductase

Therapy Area/IndicationsHypercholesterolemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSarepta Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSarepta Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A